ZA851305B - Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum - Google Patents

Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum

Info

Publication number
ZA851305B
ZA851305B ZA851305A ZA851305A ZA851305B ZA 851305 B ZA851305 B ZA 851305B ZA 851305 A ZA851305 A ZA 851305A ZA 851305 A ZA851305 A ZA 851305A ZA 851305 B ZA851305 B ZA 851305B
Authority
ZA
South Africa
Prior art keywords
processes
specific antigens
plasmodium falciparum
stage specific
recombinant dna
Prior art date
Application number
ZA851305A
Other languages
English (en)
Inventor
Bernard Mach
Luc Perring
Michael J Mcgarvey
Andrew K Cheung
Alan R Shaw
Original Assignee
Biogen Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10556870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA851305(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Nv filed Critical Biogen Nv
Publication of ZA851305B publication Critical patent/ZA851305B/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6893Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA851305A 1984-02-20 1985-02-20 Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum ZA851305B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848404378A GB8404378D0 (en) 1984-02-20 1984-02-20 Dna sequence recombinant dna molecules

Publications (1)

Publication Number Publication Date
ZA851305B true ZA851305B (en) 1986-03-26

Family

ID=10556870

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851305A ZA851305B (en) 1984-02-20 1985-02-20 Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum

Country Status (8)

Country Link
EP (1) EP0172865B2 (da)
JP (1) JPS61501547A (da)
AU (2) AU3995985A (da)
DE (1) DE3582203D1 (da)
DK (1) DK480685A (da)
GB (1) GB8404378D0 (da)
WO (1) WO1985003725A1 (da)
ZA (1) ZA851305B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
GB2154592A (en) * 1984-02-22 1985-09-11 Wellcome Found Cloning of a malarial gene
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
EP0217877A4 (en) * 1985-04-11 1988-03-30 Inst Medical W & E Hall VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
WO1987001374A2 (en) * 1985-08-28 1987-03-12 George Pieczenik Method and means for sorting and identifying biological information
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
EP0254862A1 (en) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Vaccines against protozoan parasites
AU594804B2 (en) * 1986-07-17 1990-03-15 Saramane Pty Ltd Small molecular weight antigen of plasmodium falciparum
IL83231A0 (en) * 1986-07-17 1987-12-31 Saramane Pty Ltd Small molecular weight antigen of plasmodium falciparum,antibodies directed thereto,purification and detection of said antigen
AU595056B2 (en) * 1986-07-17 1990-03-22 Program For Appropriate Technology In Health (Path) Merozoite surface antigen of plasmodium falciparum
DE3741057A1 (de) * 1987-03-18 1988-09-29 Behringwerke Ag Klonierung von malaria-spezifischen dna-sequenzen:isolierung des gens fuer das 140 kd protein
ZA888983B (en) * 1987-12-01 1989-08-30 Saramane Pty Ltd Rhoptry antigen of plasmodium falciparum
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
ES2044749B1 (es) * 1991-06-12 1994-07-16 Consejo Superior Investigacion Procedimiento para la deteccion y diagnostico de infecciones por organismos patogenos.

Also Published As

Publication number Publication date
WO1985003725A1 (en) 1985-08-29
EP0172865A1 (en) 1986-03-05
DK480685D0 (da) 1985-10-18
EP0172865B1 (en) 1991-03-20
EP0172865B2 (en) 1994-06-01
AU3995985A (en) 1985-09-10
JPS61501547A (ja) 1986-07-31
DE3582203D1 (de) 1991-04-25
GB8404378D0 (en) 1984-03-28
DK480685A (da) 1985-10-18
AU5112990A (en) 1990-11-08

Similar Documents

Publication Publication Date Title
ZA851305B (en) Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum
CS386588A2 (en) Catalyst for acrylic acid production and method of its preparation
SG77286G (en) Dna sequences, recombinant dna molecules and processes for producing human interferon-alpha like polyeptides
IL74409A0 (en) Cloning of dna for protozoal antigens
AU2992489A (en) Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
ZW25286A1 (en) Asexual blood stage antigens of plasmodium falciparum
GB2176191B (en) Antigens of plasmodium falciparum
GR871991B (en) Method for the determination of anti-p falciparum sporozoite antibodies in human blood
EP0217877A4 (en) VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
AU6687786A (en) Asexual blood stage antigens of plasmodium falciparum
IL94063A0 (en) Plasmodium circumsporozoite protein analogs lacking repeat sequences and their expression by recombinant methods
YU237588A (en) Process for preparing plasmodium falciparum proteins
IL88558A0 (en) Rhoptry antigen of plasmodium falciparum
IL97578A0 (en) Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it
ZA856960B (en) Antigens of plasmodium falciparum
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
ZA862732B (en) Highly repetitive antigens of plasmodium falciparum
AU7632191A (en) Asexual blood stage antigens of plasmodium falciparum
AU3069989A (en) Rhoptry membrane antigen of plasmodium falciparum
GB2200641B (en) Merozoite surface antigen of plasmodium falciparum
NZ221114A (en) Merozoite surface antigen of plasmodium falciparum
GB8614575D0 (en) Production of human serum albumin
RO103573B1 (ro) Procedeu de obtinere a unui liant acrilic
CS251387A1 (en) Preparation method of hydrorafinated extrudated catalyst